K PharmaInc Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Hiroaki Fukushima
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 7.9yrs |
CEO ownership | 21.0% |
Management average tenure | no data |
Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO
Hiroaki Fukushima (64 yo)
7.9yrs
Tenure
Hiroaki Fukushima is President & Representative Director of K Pharma,Inc. from November 2016. Hiroaki Fukushima Joined Eisai Co., Ltd.in 1988 and Seconded to Eisai Research Institute of Boston, Inc. in 20...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Representative Director | 7.9yrs | no data | 20.99% ¥ 1.9b | |
CFO, MD & Director | 3yrs | no data | no data | |
CTO & Director | 5yrs | no data | 11.05% ¥ 983.3m | |
CSO & Director | 5yrs | no data | 11.05% ¥ 983.3m | |
Scientific Advisor | 6.8yrs | no data | no data | |
Independent Outside Director | 1.9yrs | no data | no data | |
Outside Auditor | 2.4yrs | no data | no data | |
Outside Auditor | 5yrs | no data | no data | |
Full-time Outside Auditor | 2.6yrs | no data | no data | |
Scientific Advisor | 4.8yrs | no data | no data | |
Scientific Advisor | 5.8yrs | no data | no data |
5.0yrs
Average Tenure
63.5yo
Average Age
Experienced Board: 4896's board of directors are considered experienced (5 years average tenure).